期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
热休克蛋白在冠心病猝死病例心肌和血管中的表达及意义
1
作者 徐冰 高兴辰 +1 位作者 张洋 李志强 《牡丹江医学院学报》 2012年第3期1-3,共3页
目的:探讨冠心病猝死心肌组织和血管组织HSP70染色改变。为法医学鉴定冠心病猝死提供客观依据。方法:选择8例患冠心病但非冠心病猝死案例(A组)、10例冠心病猝死案例(B组)以及7例非冠心病死亡案例(C组).用免疫组化方法对比检测热休克蛋白... 目的:探讨冠心病猝死心肌组织和血管组织HSP70染色改变。为法医学鉴定冠心病猝死提供客观依据。方法:选择8例患冠心病但非冠心病猝死案例(A组)、10例冠心病猝死案例(B组)以及7例非冠心病死亡案例(C组).用免疫组化方法对比检测热休克蛋白70(heat shock protein70 HSP70)的表达。结果:HSP70在患冠心病但非冠心病猝死案例和冠心病猝死案例中呈阳性表达,在心肌组织中冠心病猝死组表达水平明显高于患冠心病但非冠心病猝死组(P<O.05),在血管组织中冠心病猝死组表达水平与患冠心病但非冠心病猝死组无明显差异(P>0.05),非冠心病猝死组均呈阴性表达。结论:HSP70的阳性表达是心肌和血管缺血缺氧的重要指标,对推断冠心病猝死具有一定的实际应用价值。 展开更多
关键词 冠心病猝死 热休克蛋白70 心肌和血管 免疫组织化学
下载PDF
柑橘多甲氧基黄酮化合物在心血管疾病中的应用及研究进展 被引量:3
2
作者 邓航 马敏杰 +1 位作者 于子漪 李淑珍 《沈阳医学院学报》 2021年第6期625-629,共5页
心血管疾病是目前威胁人类生命健康最主要的疾病之一,其发病率和致死率逐年增长,每年至少影响数百万人。多甲氧基黄酮化合物(PMFs)是从芸香科柑橘属植物中提取的天然产物。研究表明PMFs可通过多个靶点发挥抗炎、抗氧化、抗癌和抗诱变等... 心血管疾病是目前威胁人类生命健康最主要的疾病之一,其发病率和致死率逐年增长,每年至少影响数百万人。多甲氧基黄酮化合物(PMFs)是从芸香科柑橘属植物中提取的天然产物。研究表明PMFs可通过多个靶点发挥抗炎、抗氧化、抗癌和抗诱变等多种药理作用。PMFs在心血管疾病中的研究也越来越深入,大量研究表明PMFs在预防和治疗心血管疾病以及改善预后的过程中有出色表现,比如调节血脂异常、保护心肌和血管、抗血小板凝集和调节神经中枢等方面。本文主要针对PMFs在心血管疾病中的应用和研究进展进行综述。 展开更多
关键词 多甲氧基黄酮化合物 血管疾病 血脂异常 心肌和血管保护 抗血小板凝集
下载PDF
Patients ≥ 75 years with acute coronary syndrome but without critical epicardial coronary disease: prevalence, characteristics, and outcome
3
作者 Vincent Wong Ahmed Farah Hubertus von Korn Nedim Memisevic Stefan Richter KetevanTukhiashvili Bernward Lauer Marc-Alexander Ohlow 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2015年第1期11-16,共6页
Objective Absence of significant epicardial coronary artery disease (CAD) in patients with acute onset of chest pain and elevation of myocardial necrosis markers is occasionally observed. The aim of this study was t... Objective Absence of significant epicardial coronary artery disease (CAD) in patients with acute onset of chest pain and elevation of myocardial necrosis markers is occasionally observed. The aim of this study was to analyse the clinical characteristics and outcome of such patients with advanced age. Methods We retrospectively analysed 4,311 patients with acute onset of chest pain plus necrosis marker elevation. Two hundred and seventy two patients without CAD on angiogram (6.3%) were identified. Out of them, 50 (1.2%) patients 〉 75 years (Group Ⅰ) were compared with (1) 222 acute coronary syndrome (ACS) patients without CAD on angiogram 〈 75 years (Group Ⅱ), and (2) 610 consecutive patients ≥ 75 years with Non-ST-elevation Myocardial Infarction (NSTEMI) undergoing percutaneous coronary intervention (Group Ⅲ). Results Group 1 compared to Group III patients made up for more females (64.0% vs. 49.2%; P 〈 0.0001), and had more severe anginal symptoms on presentation [Canadian Cardiovascular Society (CCS) class Ⅰ/Ⅱ, 26.0% vs. 49.8%; P = 0.02]. Group I patients also had lower troponin levels (0.62 ± 0.8 ng/mL vs. 27 ± 74 ng/mL; P 〈 0.02), lower leukocyte count (9.4 ± 3.13 × 10^9 vs. 12 ± 5.1 × 10^9; P = 0.001 ) and better preserved left ventricular function (56.7% ± 14.3 % vs. 45% ± 1 1%; P 〈 0.0001 ). Event-free survival (cardiac death, myocardial infarction, recurrent angina, and re-hospitalisation) was more frequent in Group Ⅰ and Ⅱ patients compared to Group III patients (64.9%, 66.7%, and 41.6%, respectively; P 〈 0.0001). Conclusions ACS in patients 〉 75 years without CAD is very infrequent, associated with a (1) similar outcome compared to ACS patients 〈 75 years without CAD, and (2) significant better outcome compared to NSTEMI patients 〉 75 years. 展开更多
关键词 Acute coronary syndrome ANGINA Biological markers Coronary stenosis MYOCARDITIS Syndrome
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部